A carregar...

AQ4N: a new approach to hypoxia-activated cancer chemotherapy

Preclinical studies demonstrate that in vivo AQ4N enhances the anti-tumour effects of radiation and chemotherapeutic agents with a dose-modifying factor of approximately 2.0. With careful scheduling no, or very little, additional normal tissue toxicity should be observed. AQ4N is a bioreductive prod...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Patterson, L H, McKeown, S R
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2000
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363465/
https://ncbi.nlm.nih.gov/pubmed/11104551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1564
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!